Category

Medicine

Home » Medicine

2585 posts
Bookmark?Remove?

Antibiotics sales for use in U.S. farm animals dropped in 2016: FDA

FILE PHOTO: Turkeys stand in the warmth of the sun in their barn at Seven Acres Farm in North Reading, Massachusetts November 24, 2015, two days before the Thanksgiving holiday in the U.S. REUTERS/Brian Snyder CHICAGO (Reuters) – The sale and distribution of a... More »

Bookmark?Remove?

Sage shares surge as depression drug succeeds in mid-stage trial

(Reuters) – Drug developer Sage Therapeutics Inc’s shares soared as much as 85 percent to a record high on Thursday after its experimental drug to reduce the symptoms of depression succeeded in a mid-stage trial. Sage’s shares were up 73 percent at $159, on tr... More »

Bookmark?Remove?

Roche drug cocktail doubles chance of holding lung cancer at bay

FILE PHOTO: The logo of Swiss pharmaceutical company Roche is seen outside their headquarters in Basel, Switzerland, January 30, 2014. REUTERS/Ruben Sprich/File Photo ZURICH (Reuters) – Adding Roche’s (ROG.S) immunotherapy Tecentriq to older drugs doubled the ... More »

Bookmark?Remove?

Indivior drug to fight opioid addiction approved by U.S. FDA

(Reuters) – Indivior’s experimental drug to help fight America’s growing opioid addiction crisis was approved by the U.S. Food and Drug Administration late on Thursday, boosting its sales prospects as competitors threaten revenues from an older product. Shares... More »

Bookmark?Remove?

Foundation’s cancer gene test gets U.S. FDA and Medicare nod

CHICAGO (Reuters) – A test from Foundation Medicine Inc that can detect cancer-causing mutations in 324 genes has won approval from the U.S. Food and Drug Administration and the Center for Medicare and Medicaid Services, the agencies said. The test, known as F... More »

Bookmark?Remove?

Venezuelans suffer as malaria outbreak spreads in drug-short nation

People gather outside a health center as they wait to get treatment for malaria, in San Felix, Venezuela November 3, 2017. REUTERS/William Urdaneta CIUDAD GUAYANA, Venezuela (Reuters) – On a recent morning in Venezuela’s southern jungle state of Bolivar, Amand... More »

Bookmark?Remove?

Surrogacy: Child Trafficking or Patronage?

The list of countries where surrogacy is legal is expanding every year. In 2015, main destinations for commercial surrogacy, such as India, Nepal, Thailand and Mexico, banned this practice for foreigners. However, global demand for surrogacy is not decreasing.... More »

Bookmark?Remove?

Avatars can help schizophrenia patients control threatening voices

LONDON, Nov 23 (Reuters) – – An experimental therapy for people with schizophrenia that brings them face to face with a computer avatar representing the tormenting voices in their heads has proved promising in early stage trials. Scientists who conducted a ran... More »

Bookmark?Remove?

Three coffees a day linked to more health than harm: study

FILE PHOTO: A Cappuccino stands on a table at a branch of Costa coffee in Manchester, Britain, March 18, 2016. REUTERS/Phil Noble/File Photo LONDON (Reuters) – People who drink three to four cups of coffee a day are more likely to see health benefits than harm... More »

Bookmark?Remove?

Bayer pharmaceuticals head says there’s no pipeline problem

LEVERKUSEN, Germany (Reuters) – Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces a threat to revenues in 2024 when the blockbuster heart drug Xarelto loses its patent. The firm’s p... More »

Bookmark?Remove?

Roche announces trial successes in cancer, haemophilia

FILE PHOTO: FILE PHOTO: Swiss drugmaker Roche’s logo is seen at their headquarters in Basel, Switzerland January 28, 2016. REUTERS/Arnd Wiegmann/File Photo ZURICH (Reuters) – Roche announced a double dose of trial wins on Monday, saying its immunotherapy Tecen... More »

Bookmark?Remove?

New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS

CAPE TOWN (Reuters) – Developing new front-line antiretroviral (ARV) drugs and using technology for early diagnosis are among key steps needed to sustain momentum in fighting HIV/Aids and ending the disease as a public health threat by 2030, UNAIDS said in a r... More »

Bookmark?Remove?

U.N. calls on El Salvador to stop jailing women for abortion

FILE PHOTO: Women participate in a demonstration to ask for decriminalization of abortion in San Salvador, El Salvador, September 28, 2017. The writing on the placard reads, “My body, my rights.” REUTERS/Jose Cabezas SAN SALVADOR (Reuters) – El Salvador should... More »

Bookmark?Remove?

Steep alcohol taxes drive Turkey’s drinkers to home-brew

Onder Ceyhan, a 25-year old university student, brews his own beer at his home in Ankara, Turkey, November 6, 2017. REUTERS/Umit Bektas ANKARA (Reuters) – Carefully testing the temperature of a bucket of fermenting beer, Onder Ceyhan pushes back the foam to ad... More »

Bookmark?Remove?

U.S. drug agency to toughen stance on illicit fentanyl analogues

The U.S. Drug Enforcement Administration said on Thursday that it would classify illicit versions of the synthetic opioid fentanyl at the same level as heroin, allowing criminal prosecution of anyone who possesses, distributes or manufactures illicit versions ... More »

Bookmark?Remove?

J&J`s Stelara shows promise against lupus in study

Johnson & Johnson's blockbuster psoriasis drug Stelara led to a significant reduction in disease activity in patients with systemic lupus compared with a placebo in a midstage clinical trial, according to data released on Saturday. More »

Bookmark?Remove?

Billionaire Insys founder charged in U.S. opioid bribe case

The billionaire founder of Insys Therapeutics Inc was arrested on Thursday on U.S. charges he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug, marking a step by authorities to fight the opioid epidemic. More »

Bookmark?Remove?

Regeneron-Sanofi drug succeeds mid-stage study

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study. More »

Bookmark?Remove?

FDA panel backs gene therapy for rare form of blindness

Spark Therapeutics Inc's experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease. More »

Bookmark?Remove?

Flexion`s knee pain drug gets FDA nod, shares hit life high

Flexion Therapeutics Inc said its injectable drug to treat osteoarthritis-related knee pain was approved by the U.S. Food and Drug Administration, sending the drug developer's shares soaring to a record high in regular trading on Friday. More »

Bookmark?Remove?

Second U.S. jury finds AbbVie misrepresented risks of AndroGel

A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in a statement. More »

Bookmark?Remove?

Lilly wins Alimta patent dispute in U.S.

The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co in a patent dispute over its cancer drug Alimta with Neptune Generics LLC and Sandoz Inc. More »

Bookmark?Remove?

FDA aims to speed up arrival of complex generic drugs

The U.S. Food and Drug Administration on Monday announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan NV's emergency EpiPen in an effort to address the rising cost of pharmaceuticals. More »

Bookmark?Remove?

Makers of fast-acting opioids will have to pay for training: FDA

Makers of fast-acting opioids will have to fund voluntary training for healthcare professionals who prescribe the drugs, including education on safe prescribing practices and non-opioid alternatives, the U.S. Food and Drug Administration (FDA) said on Thursday... More »

Bookmark?Remove?

Washington state sues OxyContin maker Purdue Pharma

Washington state on Thursday sued OxyContin maker Purdue Pharma LP, becoming the latest state or local government to file a lawsuit seeking to hold pharmaceutical companies accountable for a national opioid addiction epidemic. More »

Bookmark?Remove?

FDA declines to approve J&J arthritis drug sirukumab

The U.S. Food and Drug Administration has declined to approve Johnson & Johnson's rheumatoid arthritis drug sirukumab, saying additional clinical data is needed to further evaluate its safety, the company said on Friday. More »

Bookmark?Remove?

Canada`s top marijuana producer to double production

Canada's biggest licensed producer of medical marijuana has bought land next to its greenhouse production site that will allow it to more than double the total volume of cannabis it can grow, its chief executive said on Thursday. More »

Bookmark?Remove?

New Mexico sues opioid drug manufacturers, distributors

New Mexico on Thursday sued eight opioid manufacturers and wholesale distributors, becoming the latest state or local government to file a lawsuit seeking to hold corporations accountable for a national drug addiction epidemic. More »

Bookmark?Remove?

UK report plans boost for life sciences as Brexit looms

The British government has rekindled its industrial strategy, unveiled earlier this year to prepare the economy for Brexit, with plans to boost the country's pharmaceuticals sector via fresh investments and public-private collaborations. More »

Bookmark?Remove?

Bayer, J&J in frame for bigger anti-clotting market opportunity

Bayer and Johnson & Johnson's blockbuster clot prevention drug Xarelto was shown to cut the risk of potentially deadly strokes and heart attacks in patients with severe atherosclerosis by 24 percent, raising the prospects of billions more in sales. More »